Literature DB >> 9807841

Designing ribozymes for the inhibition of gene expression.

B Bramlage1, E Luzi, F Eckstein.   

Abstract

Ribozymes are being increasingly used for the sequence-specific inhibition of gene expression by the cleavage of mRNAs encoding proteins of interest. However, particular attention must be paid to the following points: the identification of regions on the mRNA accessible to the ribozyme; the delivery of ribozymes to cells by either exogenous or endogenous delivery; colocalization of the ribozyme with the target RNA in the cell; and differentiation between closely related sequences. This field is advancing rapidly, and results obtained with transgenic animals demonstrate the power of this strategy for the inhibition of gene expression.

Mesh:

Substances:

Year:  1998        PMID: 9807841     DOI: 10.1016/s0167-7799(98)01236-0

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  10 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.

Authors:  B Bramlage; S Alefelder; P Marschall; F Eckstein
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

3.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

4.  Small, efficient hammerhead ribozymes.

Authors:  M J McCall; P Hendry; A A Mir; J Conaty; G Brown; T J Lockett
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

5.  Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.

Authors:  M Sohail; H Hochegger; A Klotzbücher; R L Guellec; T Hunt; E M Southern
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

6.  Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.

Authors:  Lucien Junior Bergeron; Jonathan Ouellet; Jean-Pierre Perreault
Journal:  Curr Med Chem       Date:  2003-12       Impact factor: 4.530

7.  Coupling of fast and slow modes in the reaction pathway of the minimal hammerhead ribozyme cleavage.

Authors:  Ravi Radhakrishnan
Journal:  Biophys J       Date:  2007-06-01       Impact factor: 4.033

8.  Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes.

Authors:  J Wrzesinski; M Legiewicz; J Ciesiołka
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

9.  A structural analysis of in vitro catalytic activities of hammerhead ribozymes.

Authors:  Yu Shao; Susan Wu; Chi Yu Chan; Jessie R Klapper; Erasmus Schneider; Ye Ding
Journal:  BMC Bioinformatics       Date:  2007-11-30       Impact factor: 3.169

10.  Inhibition of miR-21 in glioma cells using catalytic nucleic acids.

Authors:  Agnieszka Belter; Katarzyna Rolle; Monika Piwecka; Agnieszka Fedoruk-Wyszomirska; Mirosława Z Naskręt-Barciszewska; Jan Barciszewski
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.